Liao Yi-Chu, Lin Hsiu-Fen, Rundek Tatjana, Cheng Rong, Guo Yuh-Cherng, Sacco Ralph L, Juo Suh-Hang Hank
Graduate Institute of Medical Genetics, the Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Stroke. 2008 Dec;39(12):3159-65. doi: 10.1161/STROKEAHA.108.522789. Epub 2008 Sep 11.
Carotid intima-media thickness (IMT) is a surrogate marker of subclinical atherosclerosis and a strong predictor of stroke and myocardial infarction. The object of this study was to determine the association between carotid IMT and 702 single nucleotide polymorphisms in 145 genes.
B-mode carotid ultrasound was performed among 408 Hispanics from the Northern Manhattan Study. The common carotid artery IMT and bifurcation IMT were phenotypes of interest. Genetic effects were evaluated by the multivariate regression model adjusting for traditional vascular risk factors. For each individual, we calculated a gene risk score (GRS) defined as the total number of the significant single nucleotide polymorphisms in different genes. Subjects were then divided into 3 GRS categories using the 2 cutoff points: mean GRS +/-1 SD.
We identified 6 significant single nucleotide polymorphisms in 6 genes for common carotid artery IMT and 7 single nucleotide polymorphisms in 7 genes for bifurcation IMT using the probability value of 0.005 as the significant level. There were no common significant genes for both phenotypes. The most significant genes were the tissue plasminogen activator (P=0.0005 for common carotid artery IMT) and matrix metallopeptidase-12 genes (P=0.0004 for bifurcation IMT). Haplotype analysis did not yield a more significant result. Subjects with GRS >or=9 had significantly increased IMT than those with GRS <or=5 (P<0.001). GRS was an independent predictor of both common carotid artery IMT (P=2.3x10(-9)) and bifurcation MT (P=7.2x10(-8)).
Multiple genes contributed to the variation in carotid IMT. IMT in different carotid segments may be regulated by different sets of susceptibility genes.
颈动脉内膜中层厚度(IMT)是亚临床动脉粥样硬化的替代标志物,也是中风和心肌梗死的有力预测指标。本研究的目的是确定颈动脉IMT与145个基因中的702个单核苷酸多态性之间的关联。
对来自北曼哈顿研究的408名西班牙裔进行B型颈动脉超声检查。颈总动脉IMT和分叉处IMT是感兴趣的表型。通过调整传统血管危险因素的多变量回归模型评估基因效应。对于每个个体,我们计算了一个基因风险评分(GRS),定义为不同基因中显著单核苷酸多态性的总数。然后使用两个临界点将受试者分为3个GRS类别:平均GRS±1标准差。
以0.005的概率值为显著水平,我们在6个基因中鉴定出6个与颈总动脉IMT相关的显著单核苷酸多态性,在7个基因中鉴定出7个与分叉处IMT相关的单核苷酸多态性。两种表型没有共同的显著基因。最显著的基因是组织纤溶酶原激活剂(颈总动脉IMT的P=0.0005)和基质金属肽酶-12基因(分叉处IMT的P=0.0004)。单倍型分析未得出更显著的结果。GRS≥9的受试者的IMT显著高于GRS≤5的受试者(P<0.001)。GRS是颈总动脉IMT(P=2.3×10⁻⁹)和分叉处IMT(P=7.2×10⁻⁸)的独立预测指标。
多个基因导致颈动脉IMT的变异。不同颈动脉节段的IMT可能受不同组易感基因的调控。